Breethe
Breethe, Inc operates as a biotechnology company.
Launch date
Employees
Market cap
-
Enterprise valuation
$4—7m (Dealroom.co estimates Aug 2017.)
Baltimore Maryland (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $580k | Seed | |
| N/A | $2.2m | Seed | |
| N/A | $1.1m | Seed | |
| N/A | $3.0m | Debt | |
| N/A | $3.5m | Debt | |
| N/A | $8.0m | Early VC | |
* | N/A | Acquisition | |
| Total Funding | $11.9m | ||
Recent News about Breethe
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.